Session

Overview: This clinical skin cancer symposium presents evidence-based guidance for the management of high-risk non-melanoma skin cancer with examination of decision making strategies utilised in the clinic, along with review of the impact of novel genomic staging compared to currently available guidance. High-risk non-melanoma skin cancers develop the older patient population and strategies to measure the cosmetic and quality of life effects of treatment are described, sharing these tools enables radiation oncologists to help patients make informed decisions regarding their care.